These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28442990)

  • 1. Spatiotemporal and Long Lasting Modulation of 11 Key Nogo Signaling Genes in Response to Strong Neuroexcitation.
    Karlsson TE; Wellfelt K; Olson L
    Front Mol Neurosci; 2017; 10():94. PubMed ID: 28442990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nogo-Like Signaling Perspective from Birth to Adulthood and in Old Age: Brain Expression Patterns of Ligands, Receptors and Modulators.
    Smedfors G; Olson L; Karlsson TE
    Front Mol Neurosci; 2018; 11():42. PubMed ID: 29520216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential conserted activity induced regulation of Nogo receptors (1-3), LOTUS and Nogo mRNA in mouse brain.
    Karlsson TE; Koczy J; Brené S; Olson L; Josephson A
    PLoS One; 2013; 8(4):e60892. PubMed ID: 23593344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
    Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
    J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans.
    Kawakami Y; Saito Y; Nakagawa R; Kurihara Y; Takei K
    Neurosci Lett; 2018 Sep; 683():61-68. PubMed ID: 29953923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.
    Venkatesh K; Chivatakarn O; Lee H; Joshi PS; Kantor DB; Newman BA; Mage R; Rader C; Giger RJ
    J Neurosci; 2005 Jan; 25(4):808-22. PubMed ID: 15673660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
    Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
    Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
    Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
    Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatio-temporal expression pattern of receptors for myelin-associated inhibitors in the developing rat olfactory system.
    Richard M; Sacquet J; Jourdan F; Pellier-Monnin V
    Brain Res; 2009 Feb; 1252():52-65. PubMed ID: 19063867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-induced and developmental downregulation of the Nogo receptor.
    Josephson A; Trifunovski A; Schéele C; Widenfalk J; Wahlestedt C; Brené S; Olson L; Spenger C
    Cell Tissue Res; 2003 Mar; 311(3):333-42. PubMed ID: 12658441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.
    Zhang L; Kuang X; Zhang J
    J Genet Genomics; 2011 Nov; 38(11):515-23. PubMed ID: 22133682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l.
    Llorens F; Gil V; Iraola S; Carim-Todd L; Martí E; Estivill X; Soriano E; del Rio JA; Sumoy L
    Dev Neurobiol; 2008 Mar; 68(4):521-41. PubMed ID: 18186492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
    Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
    Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B.
    Kurihara Y; Takai T; Takei K
    J Neurochem; 2020 Nov; 155(3):285-299. PubMed ID: 32201946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal activity-induced regulation of Lingo-1.
    Trifunovski A; Josephson A; Ringman A; Brené S; Spenger C; Olson L
    Neuroreport; 2004 Oct; 15(15):2397-400. PubMed ID: 15640763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous system.
    Funahashi S; Hasegawa T; Nagano A; Sato K
    J Comp Neurol; 2008 Jan; 506(1):141-60. PubMed ID: 17990276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.
    Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM
    J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
    Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
    J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective decline of Nogo mRNA in the aging brain.
    Trifunovski A; Josephson A; Bickford PC; Olson L; Brené S
    Neuroreport; 2006 Jun; 17(9):913-6. PubMed ID: 16738487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
    Saha N; Kolev M; Nikolov DB
    Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.